Buccal drug delivery

Expert Opinion on Drug Delivery

Volumn 2, Issue 3, 2005, Pages 507-517

  Smart, John D ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Absorption; Bioadhesion; Buccal; Buccoadhesion; Mucoadhesion

Indexed keywords

AMLEXANOX; APHTACH; BIOPOLYMER; CARBAMAZEPINE; CELLULOSE DERIVATIVE; CHLORHEXIDINE; CHLORPHENIRAMINE; COD LIVER OIL; DENBUFYLLINE; DENTIPATCH; DEXTRAN; ERGOTAMINE; ESTRADIOL; FENTANYL CITRATE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLYCEROL OLEATE; GLYCERYL TRINITRATE; INSULIN; LAUROCAPRAM; LECTIN; LIDOCAINE; MANNITOL; OLIGONUCLEOTIDE; OMEPRAZOLE; ORAVESCENT; POLYACRYLIC ACID; PROCHLORPERAZINE MALEATE; PROTEIN DERIVATIVE; SUSCARD BUCCAL; TESTOSTERONE; THEOPHYLLINE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG;

ADHESION; CHEEK MUCOSA; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG TRANSPORT; FILM; FUNCTIONAL ANATOMY; GENOMICS; HUMAN; HYDROGEN BOND; HYDROPHILICITY; LIQUID; MACROMOLECULE; MOLECULAR SIZE; NONHUMAN; PERMEABILITY; PROTEOMICS; REVIEW; SOLID; TABLET FORMULATION;

ABSORPTION; ADHESIVES; ADMINISTRATION, BUCCAL; DRUG DELIVERY SYSTEMS; HUMANS; MOUTH MUCOSA; PHARMACEUTICAL PREPARATIONS;

EID: 28044460290     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2.3.507     Document Type: Review

References (92)

1. TYERS M, MANN M: From genomics to proteomics. Nature (2003) 422:193-197.
2. BETZ SF, BAXTER SM, FETROW JS: Function first: a powerful approach to post genomic drug discovery. Drug Discov. Today (2002) 7:8765-871.
3. MEYER JM, GINSBURG GS: The path to personalised medicine. Curr. Opin. Biol. (2002) 6:434-438.
4. GURWITZ D, WIEZMAN A, REHAVI M: Teaching pharmacogenomics to prepare future physicians and researchers for personalised medicine. Trends Pharmacol. Sci. (2003) 24:122-125.
5. WILSON CG, WASHINGTON N: Drug delivery to the oral cavity. In: Physiological Pharmacuetics, biological barriers to drug absorption. CG Wilson, N Washington (Eds), Ellis Horwood, Chichister, UK (1989):21-36.
6. SAMARANAYAKE LP, FERGUSON MM: Delivery of antifungals to the oral cavity. Adv. Drug Deliv. Rev. (1994) 13:161-179.
7. HARRIS D, ROBINSON JR: Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. (1992) 81:1-10.
8. RATHBONE MJ, DRUMMOND BK, TUCKER IG: The oral cavity as a site for systemic drug delivery. Adv. Drug Deliv. Rev. (1994) 13:1-22.
9. SMART JD: Drug delivery using buccal adhesive systems. Adv. Drug Deliv. Rev. (1993) 11:253-270.
10. WHEATHERELL JA, ROBINSON C, RATHBONE MJ: Site specific differences in the salivary concentrations of substances in the oral cavity - implications for the aetiology of oral disease and local drug delivery. Adv. Drug Deliv. Rev. (1994) 13:23-42.
11. MCPHERSON LMD, DAWES C: Distribution of sucrose around the mouth and clearance after a sucrose mouthrinse or consumption of three different foods. Caries Res. (1994) 28:150-155.
12. VIVIEN-CASTIONI N, GURNY R, BAENHI P, KALSATOS V: Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses. Eur. J. Pharm. Biopharm. (2000) 49:27-33.
13. HAO J, HENG PWS: Buccal delivery systems. Drug Dev. Ind. Pharm. (2003) 29:821-832.
14. EVESON JW, SCULLY C: Color atlas of oral pathology. Mosby-Wolfe, London, UK (1995).
15. GHANDI RB, ROBINSON JR: Oral cavity as a site for bioadhesive drug delivery. Adv. Drug Deliv. Rev. (1994) 13:43-74
16. SQUIER CA, WERTZ PW: Permeability and pathophysiology of the oral mucosa. Adv. Drug Deliv. Res. (1993) 12:13-24
17. HERRARA JL, LYONS MF, JOHNSON LF: Saliva: its role in health and disease. J. Clin. Gastroenterol. (1988) 10:569-578.
18. SLOMIANY BL, MURTY VL, PIOTROWSKI J, SLOMLIANY A: Salivary mucins in oral mucosal defence. Gen. Pharmac. 1996; 27:761-771.
19. BRADWAY SD, BERGEY EJ, JONES PC, LEVINE MJ: Oral mucosal pellicle. Biochem. J. (1989) 261:887-896.
20. COLLINS LM, DAWES C: The surface area of the adult human mouth and thickness of the salivary film covering the teeth and the oral mucosa. J. Dent. Res. (1987) 66:1300-1302.
21. ADDY M: Local delivery of antimicrobial agents to the oral cavity. Adv. Drug Deliv. Rev. (1994) 13:123-134.
22. VEUILLEZ F, KALIA YN, JACQUES Y, DESHUSSES J, BURI P: Factors and strategies for improving buccal absorption of peptides. Eur. J. Pharm. Biopharm. (2001) 51:93-109.
23. KUROSAKI Y, KIMURA T: Regional variation in oral mucosal drug permeability. Crit. Rev. Therap. Drug Carrier Syst. (2000) 17:467-508.
24. SQUIER CA, LESCH CA: Penetration pathways of different compounds through epidermis and oral epithelia. J. Oral Pathol. (1988) 17:512-516.
25. JUNGINGER H, HOOGSTRAATE J, VERHOEF J, Recent advances in buccal drug delivery and absorption--in vitro and in vivo studies. J. Control. Rel. (1999) 62:149-159.
26. SONG Y, WANG Y, THAKUR R, MEIDEN VMMICHNIAK B: Mucosal drug delivery: membranes, methodologies and applications. Crit. Rev. Therap. Drug CarrierSyst. (2004) 21:195-256.
27. SHOJAEI AM: Buccal mucosa as a route for systemic drug delivery, a review. J. Pharm. Pharmacuet. Sci. (1998) 1:15-30.
28. FLORENCE AT, ATTWOOD DA: Buccal and sublingual absorption. In: Physicochemical Principals of Pharmacy. Palgrave, Basingstoke, UK (1998):392.
29. KUROSAKI Y, NISHIMURA H, TERAO K, NAKAYAMA T, KIMURA T: Existence of a specialised absorption mechanism for cefadroxil, an aminocephalosporin antibiotic, in the human oral cavity. Int. J. Pharm. (1992) 82:165-169.
30. KUROSAKI Y, YANO K, KIMURA T, Perfusion cells for studying regional variation in oral mucosal permeability in humans. 2. A specialized transport mechanism in D-glucose absorption exists in dorsum of tongue. J. Pharm. Sci. (1998) 87:613-615.
31. 1.7] - eel calcitonin from various mucosal administration sites J. Control. Rel. (2001) 76:363-374.
32. SENEL S, HINCAL AA: Drug permeation enhancement via the buccal route: possibilities and limitations. J. Control. Rel. (2001) 72:133-144.
33. MORISHITA M, BARICHELLO JM, TAKAYAMA K, CHIBA Y, TOKIWA S, NAGAI T: Pluronic F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin. Int. J. Pharm. (2001) 212:289-293.
34. TSUTSUMI K, OBATA Y, NAGAI T, LOFTSSON T, TAKAYAMA K: Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea pigs. Int. J. Pharm. (2002) 238:161-170.
35. PORTERO A, REMUNAN-LOPEZ C, NIELSEN, HM: The potential of chitosan in enhancing peptide and protein absorption across the TR146 cell culture model-an in vitro model of the buccal epithelium. Pharm. Res. (2002) 19:169-174.
36. 5]enkephalin from liquid crystalline phases of glyceryl monooloeate. Int. J. Pharm. (2000) 195:3538.
37. NICLAZZO JA, REED BL, FINNIN BC: Modification of buccal delivery following pre-treatment with skin penetration enhancers. J. Pharm. Sci. (2004) 93(8):2054-2063.
38. YAMAMOTO A, HAYAKAWA E, LEE VH: Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: implications in peptide drug delivery rom non-oral routes. Life Sci. (1990) 47:2465-2474.
39. TAVAKOLI-SABERI MR, WILLIAMS A, AUDUS KL: Aminopeptidase activity in human buccal epithelium and primary cultures of hamster buccal epithelium. Pharm. Res. (1991) 6:S197.
40. BURNSIDE BA, KEITH AD, SNIPES W: Microporous hollow fibres as a peptide delivery system for the buccal cavity. Proc. Int. Symp. Control. Rel. Bioact. Mater. (1989) 16:93-94.
41. SMART JD: Bioadhesion. In: Encyclopaedia of Biomaterials and Biomedical Engineering. GE Wnek, GL Bowlin (Eds), Marcel Dekker, New York, NY, USA (2004):62-71.
42. HARDING SE, DAVIS SS, DEACON MP, FIEBRIG I: Biopolymer mucoadhesives. Biotechnol. Genet. Eng. Revs. (1999) 6:41-85.
43. LEE JW, PARK JH, ROBINSON JR: Bioadhesive-based dosage forms: the next generation. J. Pharm. Sci. (2000) 89:850-866.
44. SMART JD: The basics and underlying mechanisms of mucoadhesion. Adv. Drug Deliv. Rev. (In press).
45. AHUJA A, KHAR RP, ALI J: Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm. (1997) 23:489-515.
46. BERNKOP-SCHNURCH A, SCHOLLER S, BIEBEL RG: Development of controlled release systems based on thiolated polymers. J. Control. Rel. (2000) 66:39-48.
47. BERNKOP-SCHNURCH A, KAST CE, RICHTER MF: Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J. Control. Rel. (2001) 71:277-285.
48. BERNKOP-SCHNURCH A, CLAUSEN AE, HNATYSZYN M: Thiolated polymers, synthesis and in vitro evaluation of polymer-cysteamine conjugates. Int. J. Pharm. (2001) 226:185-194.
49. KAST CE, BERNKOP-SCHNURCH A: Thiolated polymers-thiomers: development and in vitro evaluation of chitosan - thiolglycolic acid conjugates. Biomaterials (2001) 22:2345-2352.
50. GUGGI D, MARSCHULTZ MK, BERNKOP-SCHNURCH A: Matrix tablets based on thiolated poly (acrylic acid): pH dependent variation in distintegration and mucoadhesion. Int. J. Pharm. (2004) 274:97-105.
51. LANGOTH N, KALBE J, BERNKOP-SCHNURCH A: Development of buccal drug delivery systems based on a thiolated polymer. Int. J. Pharm. (2003) 252:141-148.
52. LEITNER VM, WALKER GF, BERNKOP-SCHNURCH A: Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. Europ. J. Pharm. Biopharm. (2003) 56:207-214.
53. LEE J, YOUNG SA, KELLAWAY IW: Water quantitatively induces the mucoadhesion of liquid crystalline phases of glyceryl monooleate. J. Pharm. Pharmacol. (2001) 53:629-636.
54. SMART JD: An in vitro assessment of some mucosa-adhesive dosage forms. Int. J. Pharm. (1991) 73:69-74.
55. SMART JD: Recent developments in the use of bioadhesive buccal systems for local and systemic delivery of drugs. Crit. Rev. Therap. Drug Carrier Syst. (2004) 21(4):319-344.
56. NAGAI T: Topical mucosal adhesive dosage forms. Med. Res. Rev. (1986) 6(2):227-242.
57. VENUGOPALAN P, SAPRE A, VENKATESAN N, VYAS SP: Pelleted bioadhesive polymeric nanoparticles for the buccal delivery of insulin: preparation and characterization. Pharmazie (2001) 56:217-219.
58. TIWARI D, GOLDMAN D, TOWN C, SAUSE R, MADAN PL: In vitro - in vivo evaluation of a controlled release buccal bioadhesive device for oral drug delivery. Pharm. Res. (1999) 16:1775-1780.
59. TIWARI D, SAUSE R, MADAN PL, GOLDMAN D: Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations. AAPS Pharmsci (1999) 1(3):E13.
60. CHOI HG, KIM CK: Development of omeprazole buccal adhesive tablets stability enhancement in human saliva. J. Control. Rel. (2000) 68:397-404.
61. IKINCI G, CAPAN Y, SENEL S, ALAADDINOGLU E, DALKARA T, HINCAL AA: In vitro in vivo studies on a buccal bioadhesive tablet formulation of carbamezepine. Pharmazie (2000) 55:762-765.
62. MARTIN L, WILSON CG, KOOSHA F, TETLEY L, GRAY AL, SEVDA S, UCHEGBU IF: The release of model macromolecules may be controlled by the hydrophobicity of palmitoyl glycol chitosan hydrogels. J. Contr. Rel. (2002) 80:87-100.
63. MARTIN L, WILSON CG, KOOSHA F, UCHEGBU IF: Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Europ. J. Pharm. Biopharm. (2003) 55:35-45.
64. COESSENS P, HERREBOUT F, DE BOEVER JA, VOORSPOELS J, REMON JP: Plaque inhibiting effect of bioadhesive mucosal tablets containing chlorhexidine in a 4-day plaque regrowth model. Clin. Oral Invest. (2002) 6:217-212.
65. AMEYE D, VOORSPOELS J, FOREMAN P et al.: Ex vivo bioadhesion and in vivo testosterone bioavailability study of different bioadhesive formulations based on starch-g-poly(acrylic acid) copolymers and starch/poly(acrylic acid) mixtures. J. Control. Rel. (2002) 79:173-182.
66. GERESH S, GDALEVSKY GY, GILBOA I, VOORSPOELS J, REMON JP, KOST J: Bioadhesive grafted copolymers as platforms for peroral drug delivery: a study of theophylline release. J. Control. Rel. (2004) 94:391-399.
67. JAIN AC, AUNGST BJ, ADEYEYE MC: Development and in-vitro evaluation of buccal tablets prepared using danazolsulfobutylether 7 β-cyclodextrin (SBE 7) complexes. J. Pharm. Sci. (2002) 91:1659-1668.
68. MERKLE HP, ANDERS R, WERMERSKIRCHEN A: Mucoadhesive buccal patches for peptide delivery. In: Bioadhesive drug delivery systems. V Lenaerts, R Gurny (Eds), CRC Press, Boca Raton, FL, USA (1990):105-136.
69. SHOJAEI AH, PAULSON J, HONARY S: Evaluation of poly(acrylic acid-coethylhexyl acrylate) films for mucoadhesive transbuccal drug delivery: factors affecting the force of mucoadhesion. J. Contr. Rel. (2000) 67:223-232.
70. SHARMA P, HAMSA V: Formulation and evaluation of buccal mucoadhesive patches of terbutalene sulphate. STP Pharma. Sci. (2001) 11:275-281.
71. ROSSI S, SANDRI G, FERRARI F, BONFERONI MC, CARAMELLA C: Buccal delivery of acyclovir from films based on chirosan and polyacrylic acid. Pharm. Dev. Technol. (2003) 8:199-208.
72. NAFEE NA, ISMAIL FA, BORAIE NA, MORTADA LM: Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Int. J. Pharm. (2003) 264:1-14.
73. KOCKISCH S, REES GD, YOUNG SA, TSIBOUKLIS J, SMART JD: Polymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential. J. Pharm. Sci. (2003) 92:1614-1623.
74. KOCKISCH S, REES, GD, YOUNG SA, TSIBOUKLIS J, SMART JD: In-situ evaluation of drug-loaded microspheres on a mucosal surface under dynamic rest conditions. Int. J. Pharm. (2004) 276:51-58.
75. JONES DS, IRWIN CR, WOOLFSON AD, DJOKIC J, ADAMS V: Physochemical characterisation and preliminary in vivo efficacy of bioadhesive, semisolid formulations containing flurbiprofen for the treatment of gingivitis. J. Pharm. Sci. (1999) 88:592-598.
76. JONES DS, WOOLFSON, AD, BROWN AF: Viscoelastic properties of bioadhesive chlorhexidine containing semisolids for topical application to the oropharynx. Pharm. Res. (1998) 15:1131-1136.
77. JONES DS, LAWLOR MS, WOOLFSON AD: Rheological and mucoadhesive characterisation of polymeric systems composed of poly(methylvinylether-co-maleic anhydride) and poly(vinylpyrrolidone), designed as platforms for topical drug delivery. J. Pharm. Sci. (2003) 92:995-1007.
78. SHIN SJ, BUM JP, CHOI JS: Enhanced bioavailability by buccal administration of triamcinolone acetonide from bioadhesive gels in rabbits. Int. J. Pharm. (2000) 209:37-43.
79. PARK JS, YOON JI, LI H, MOON DC, HAN K: Buccal mucosal ulcer healing effect of rhEGF/Eudispert hv hydrogel. Arch. Pharm. Res. (2003) 26:659-665.
80. PETELIN M, PAVLICA Z, BIZIMOSKA S, SENTJURC M: In vivo study of different ointments for drug delivery into oral mucosa by EPR oximetry. Int. J. Pharm. (2004) 270:83-91.
81. SIGARDSSON HH, KNUDSEN E, LOFTSSON T, LEEVES N, SIGURJONSDOTTIR JF, MASSON M: Mucoadhesive sustained drug delivery system based on cationic polymer and anionic cyclodextrin/triclosan complex. J. Incl. Phenom. Macrocycl. Chem. (2002) 44:169-172.
82. PATEL D, SMITH AW, GRIST N, BARNETT P, SMART JD: In-vitro mucosal model predictive of bioadhesive agents in the oral cavity. J. Control. Rel. (1999) 61:175-183.
83. PATEL D, SMITH JR, SMITH AW, GRIST NW, BARNETT P, SMART JD: An atomic force microscopy investigation of bioadhesive polymer adsorption onto human buccal cells. Int. J. Pharm. (2000) 200:271-277.
84. KOCKISCH S, REES GD, YOUNG SA, TSIBOUKLIS J, SMART JD: A direct-staining method to evaluate the mucoadhesion of polymers from aqueous dispersion. J. Contr. Rel. (2001) 77:1-6.
85. SCHMIDGALL J, SCHNETZ E, HENSEL A: Evidence for bioadhesive effects of polysaccharides and polysaccharide-containing herbs in an ex vivo bioadhesion assay on buccal membranes. Plant Medica (2000) 66:48-53.
86. SHARON N: Lectin-carbohydrate complexes of plants and animals: an atomic view. Trends Biochem. Sci. (1993) 18:221-226.
87. SMART JD: Lectin-mediated drug delivery in the oral cavity. Adv. Drug Deliv. Revs. (2004) 56: 481-489.
88. SMART JD, NANTWI PKK, ROGERS DJ, GREEN KL: A quantitative evaluation of radiolabelled lectin retention on oral mucosa in-vitro and in vivo. Europ. J. Pharm. Biopharm. (2002) 53: 289-292.
89. HOOGSTRAATE JA, WERTZ PW: Drug delivery via the buccal mucosa. Pharm. Sci. Tech. Today (1998) 1(7):309-316.
90. BOTTENBURG P, CLAYMAET R et al.: Development and testing of bioadhesive fluoride-containing slow-release tablets for oral use. J. Pharm. Pharmacol. (1991) 43:457-464.
91. SMART JD, MORTAZAVI SA: An investigation of the pH within the hydrating gel layer of a poly (acrylic acid) compact. J. Pharm. Pharmac. (1995) 47:1099.
92. SMART JD, BANCHONGLIKITKUL C, GIBBS RV, DONOVAN SJ, COOK DJ: Lectins in drug delivery to the oral cavity, in-vitro toxicity studies. STP Pharma Sci. (2003) 13:37-40.